Expression of microRNA-495-5p in preterm infants with bronchopulmonary dysplasia: a bioinformatics analysis.
- Author:
Yi-Fan SUN
1
;
Li MA
;
Xiao-Hui GONG
;
Wen-Chao HONG
;
Cheng CAI
Author Information
1. Department of Neonatology, Shanghai Children's Hospital/Shanghai Jiaotong University, Shanghai 200062, China. caicheng2004@163.com.
- Publication Type:Journal Article
- MeSH:
Bronchopulmonary Dysplasia;
Computational Biology;
Humans;
Infant, Newborn;
Infant, Premature;
MicroRNAs;
genetics;
Transcription, Genetic
- From:
Chinese Journal of Contemporary Pediatrics
2020;22(1):24-30
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To study the expression of microRNA-495-5p (miRNA-495-5p) in the serum of preterm infants with bronchopulmonary dysplasia (BPD) based on a bioinformatics analysis, and to provide a theoretical basis for further research on the association between miRNA-495-5p and BPD.
METHODS:A total of 40 preterm infants who were admitted to the neonatal intensive care unit from January 2015 to December 2016 were enrolled. Among these infants, 20 with early clinical manifestations of BPD were enrolled as the BPD group, and 20 without such manifestations were enrolled as the control group. Peripheral blood samples were collected. The miRNA microarray technique was used to screen out differentially expressed miRNAs in serum between the two groups. RT-PCR was used for validation of results. TargetScan, miRDB, and miRWalk databases were used to predict the target genes of miRNA-495-5p. The DAVID database was used to perform gene ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of the target genes.
RESULTS:Compared with the control group, the BPD group had a significant increase in the expression of miRNA-495-5p in serum (P<0.05). A total of 117 target genes of miRNA-495-5p were predicted by the above three databases and they were involved in several molecular functions (including transcriptional regulatory activity, transcriptional activation activity, and transcription cofactor activity), biological processes (such as metabolic regulation, DNA-dependent transcriptional regulation, and vascular pattern), and cell components (including nucleoplasm, membrane components, and insoluble components) (P<0.05). As for signaling pathways, these genes were significantly enriched in the mTOR signaling pathway (P<0.05).
CONCLUSIONS:MiRNA-495-5p may be involved in the development and progression of BPD by regulating angiogenesis, stem cell differentiation, apoptosis, and autophagy, which provides clues for further research on the role and functional mechanism of miRNA-495-5p in BPD.
